InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Grove Robert Earle, Director. Director active across 1 companies, notably IRIDEX CORP. Aggregated, 5 filings have been published. Total volume traded: €18k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
027,472 shares0
Common Stock
SEC:0001209191-22-037550:0·
€8,8331,644 shares@ €5.3730.050% mcap100.0% of flow
Common Stock
SEC:0001209191-21-067672·
Ideal exit: 29 Aug 2022 (T+270)
€8,8331,644 shares@ €5.3730.050% mcap50.0% of flow
Common Stock
SEC:0001209191-21-067672:0·
Ideal exit: 29 Aug 2022 (T+270)
05,420 shares0
Common Stock
SEC:0001209191-21-042265·
05,420 shares0
Common Stock
SEC:0001209191-21-042265:0·
5 of 5 declarations
About Grove Robert Earle
Grove Robert Earle is a Board Member at IRIDEX CORP. He brings valuable expertise in the medical field, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
